D-0155-2026 Class II Ongoing

Recalled by Aero Healthcare — Valley Cottage, NY

FDA drug recall D-0155-2026 was initiated by Aero Healthcare on Oct 17, 2025 and is designated Class II. Reason for recall: Labeling: Label Mix-up. This issue affects the outer box labeling only. The box incorrectly states the ingredients Acetaminophen 500mg and Caffeine 65mg. The inner pouch correctly states the… The recall status is ongoing.

Recall details

Product Type
Drugs
Report Date
Nov 12, 2025
Initiation Date
Oct 17, 2025
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Acetaminophen 500mg Caffeine 65mg caplets, packaged as 2 caplets per packet further packaged in a 50-count box, AERO TAB, Manufactured for AERO HEALTHCARE US, Valley-Cottage, NY, 10989, NDC 55305-135-01

Reason for recall

Labeling: Label Mix-up. This issue affects the outer box labeling only. The box incorrectly states the ingredients Acetaminophen 500mg and Caffeine 65mg. The inner pouch correctly states the ingredients are Aspirin (NSAID)*500mg and Caffeine 32.5mg.

Distribution pattern

US Nationwide.

Code information

Lot # 9282, Exp Date: 2026-09-01; Lot # 9310, Exp Date: 2026-11-01

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0155-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0155-2026. Report a data issue: hello@regdatalab.com.